Secondary malignancies in non‐Hodgkin lymphoma survivors: 40 years of follow‐up assessed by treatment modality by Matthew W. Parsons, Calvin Rock, Jonathan J. Chipman, Harsh R. Shah, Boyu Hu, Deborah M. Stephens, Randa Tao, Jonathan D. Tward, David K. Gaffney

Get full text

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patie... by Simonetta Viviani, Chiara Pavoni, Sally F. Barrington, Luca Guerra, Heiko Schöder, Peter Johnson, Amy A. Kirkwood, Deborah M. Stephens, Jonathan W. Friedberg, Stephane Chauvie, Michael V. Knopp, Massimo Federico, Gunilla Enblad, Paolo Corradini, Andrea Gallamini, Alessandro Rambaldi, Corrado Tarella

Get full text

Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy by Calvin B. Rock, MD, Jonathan J. Chipman, PhD, Matthew W. Parsons, MD, Chris R. Weil, MD, Ryan J. Hutten, MD, Randa Tao, MD, Jonathan D. Tward, MD, PhD, Harsh R. Shah, DO, Boyu Hu, MD, Deborah M. Stephens, DO, David K. Gaffney, MD, PhD

Get full text

P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma by Harsh Shah, Victoria Vardell, Erin Zacholski, Amanda Fegley, Kalub Fedak, Suchitra Sundaram, Sridevi Rajeeve, Gaurav Goyal, Haris Hatic, Pallawi Torka, Sheeba Ba Aqeel, Azra Borogovac, Kira Macdougall, Shalin Kothari, Anna Kress, Dipenkumar Modi, Elizabeth Travers, Nitin Chilakamarri, Elizabeth Brem, Deborah M. Stephens, Boyu Hu, Lindsey Fitzgerlad, Charlotte Wagner, Daniel Ermann

Get full text

Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study by Narendranath Epperla, Lei Feng, Nirav N. Shah, Lindsey Fitzgerald, Harsh Shah, Deborah M. Stephens, Catherine J. Lee, Thomas Ollila, Geoffrey Shouse, Alexey V. Danilov, Kevin A. David, Pallawi Torka, Hamza Hashmi, Brian Hess, Stefan K. Barta, Jason T. Romancik, Jonathon B. Cohen, Kaitlin Annunzio, Adam S. Kittai, John Reneau, Joanna Zurko, Imran A. Nizamuddin, Jane N. Winter, Leo I. Gordon, Shuo Ma, Romil Patel, Loretta Nastoupil, Sairah Ahmed, Reem Karmali

Get full text

Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle... by Julie M. Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K. Link, Melissa H. Cessna, Paul M. Barr, Brad S. Kahl, Matthew S. Mckinney, Nadia Khan, Ranjana H. Advani, Peter Martin, Andre H. Goy, Tycel J. Phillips, Amitkumar Mehta, Manali Kamdar, Michael Crump, Barbara Pro, Christopher R. Flowers, Caron A. Jacobson, Sonali M. Smith, Deborah M. Stephens, Veronika Bachanova, Zhaohui Jin, Shishou Wu, Francisco Hernandez-Ilizaliturri, Pallawi Torka, Andrea Anampa-Guzmán, Farshid Kashef, Xing Li, Sunandini Sharma, Timothy C. Greiner, James O. Armitage, Matthew Lunning, Dennis D. Weisenburger, Robert G. Bociek, Javeed Iqbal, Guohua Yu, Chengfeng Bi, the North American Mantle Cell Lymphoma Consortium

Get full text